<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T19:43:12Z</responseDate><request verb="GetRecord" identifier="oai:digital.lib.washington.edu:1773/48997" metadataPrefix="dim">https://digital.lib.washington.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:digital.lib.washington.edu:1773/48997</identifier><datestamp>2026-06-09T17:12:58Z</datestamp><setSpec>com_1773_4888</setSpec><setSpec>col_1773_4918</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Winer, Rachel L</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" authority="b2614fba-cb0f-427b-9b1d-09e5df2b0b17" confidence="300">Vasavada, Anjali</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2022-07-14T22:11:12Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2022-07-14T22:11:12Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2022-07-14</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="submitted">2022</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">Vasavada_washington_0250O_24359.pdf</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/1773/48997</dim:field>
   <dim:field mdschema="dc" element="description">Thesis (Master&amp;apos;s)--University of Washington, 2022</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract">Background: HIV-positive individuals remain at risk for anal cancer and will likely benefit from research that prioritizes early detection of anal cancer and optimized screening practices. We 
assessed host deoxyribonucleic acid (DNA) methylation markers for detecting high-grade anal 
intraepithelial neoplasia (AIN) versus low-grade AIN or normal samples in HIV-positive 
individuals in Seattle, Washington.
Methods: HIV-positive individuals ≥18 years of age and with assigned male sex at birth were 
recruited at anal cancer screening, diagnosis, or treatment visits at the Harborview Medical 
Center Madison Clinic in Seattle, Washington between 2015 and 2016. Anal brush samples
were collected by an anoscopist for HPV genotyping and pyrosequencing methylation analysis. 
Demographic and clinical data, as well as anal cancer screening, diagnosis, and treatment 
results, were collected through chart abstraction and review of electronic medical record (EMR)
data. The exposures were the mean percent of DNA methylation for genes ASCL1, PAX1, 
FMN2 and ATP10A. The primary outcome was AIN grade, dichotomized as normal/low gradeAIN and high-grade AIN, determined by clinically available histology and cytology results from 
the same visit. Generalized estimating equation (GEE) logistic regression was used to estimate 
odds ratios (ORs) and 95% confidence intervals (CI) to assess the associations between 
methylation and high-grade disease, adjusted for age, HIV viral load and CD4 count. The 
performance of a marker panel was assessed by measuring sensitivity and specificity of a 
model at the Youden’s index threshold using genes that were individually associated with highgrade AIN detection. A sensitivity analysis measuring high-grade disease extent was conducted 
using ordinal GEE logistic regression.
Results: 125 samples were analyzed from 85 participants. The mean age of participants was 
50.3 (SD 10.2) years, their mean CD4 count was 568 (SD 348) cells/µl and 94.2% had an 
undetectable HIV viral load. Methylation of ASCL1 (aOR per 1 unit increase in mean percent 
methylation 1.07, 95% CI 1.01, 1.13) and FMN2 (aOR per 1 unit increase in mean percent 
methylation 1.12, 95% CI 1.06, 1.19) were significantly associated with high-grade AIN versus 
low-grade AIN/normal. Mean percent methylation of PAX1 and ATP10A did not show significant 
associations with high-grade disease. A marker panel combining ASCL1 and FMN2 had a 
sensitivity of 90.4% for high-grade AIN and a specificity of 45.6%. Methylation of ASCL1 (OR 
1.06, 95% CI 1.01, 1.11) and FMN2 (OR 1.07, 95% CI 1.02, 1.10) were each positively 
associated with increasing extent of high-grade disease, indicating a dose-response effect.
Discussion: Increasing levels of DNA methylation of ASCL1 and FMN2 were positively 
associated with high-grade AIN detection. With further validation studies, self-sampling host 
gene methylation testing has promise to be an effective screening and triage tool for anal 
cancer.</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en_US</dim:field>
   <dim:field mdschema="dc" element="rights">CC BY</dim:field>
   <dim:field mdschema="dc" element="subject">anal</dim:field>
   <dim:field mdschema="dc" element="subject">biomarkers</dim:field>
   <dim:field mdschema="dc" element="subject">cancer</dim:field>
   <dim:field mdschema="dc" element="subject">cytology</dim:field>
   <dim:field mdschema="dc" element="subject">histology</dim:field>
   <dim:field mdschema="dc" element="subject">methylation</dim:field>
   <dim:field mdschema="dc" element="subject">Epidemiology</dim:field>
   <dim:field mdschema="dc" element="subject">Statistics</dim:field>
   <dim:field mdschema="dc" element="subject">Medicine</dim:field>
   <dim:field mdschema="dc" element="subject" qualifier="other">Epidemiology</dim:field>
   <dim:field mdschema="dc" element="title">Methylation markers for anal cancer screening: a repeated cross-sectional analysis of HIV-positive individuals, 2015-2016</dim:field>
   <dim:field mdschema="dc" element="type">Thesis</dim:field>
   <dim:field mdschema="dc" element="embargo" qualifier="terms">Open Access</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>